The Weekly Dose
THIS WEEK'S QUESTION Why are so many women suddenly wearing an estrogen patch? π€ This week, a well-known menopause doctor posted one number, and thousands of women jumped into the comments.
In June 2024, there were about 594,000 prescriptions for estradiol patches. By May 2026? About 1.6 million. That comes from the health-data company HealthVerity, as reported by CBS News.
Quick decoder: estradiol is a form of estrogen, the hormone that drops around menopause. The patch sits on your skin. Doctors use it to treat menopause symptoms like hot flashes and night sweats.
The patches got so popular that the FDA says the supply nearly doubled in just one year. The companies that make them are adding work shifts and building bigger batches to keep up.
The doctor's point was clear. This isn't a fad. This is women coming back to something they walked away from twenty years ago.
So why did they walk away? And why are they coming back now? It comes down to one little box on a label. π
π€― INTERESTING FACT Pop quiz: where did one of the first big estrogen medicines come from? π΄
In 1941, a Canadian drug company launched an estrogen medicine called Premarin.
The answer is hiding in the name. PREgnant MARes' urINe.
At first, scientists got their estrogen from the urine of pregnant women. Then they found out pregnant horses make the same hormones, or very close to them.
And a horse makes a whole lot more pee than a person does.
So for decades, one of the best-known menopause medicines started out in a barn. Talk about horse sense. π
ONE THING WORTH KNOWING What a βblack boxβ warning really is the loudest label a medicine gets Unfold the paper that comes with some medicines and you may spot a few lines with a thick black border around them. That's a boxed warning, often called a black box. It's the strongest warning the FDA can put on a drug, one step short of pulling it off the market. Hormone therapy got one in 2003, after a big study made headlines. Later, the FDA pointed out that the women in that study were 63 on average. That's more than ten years past the usual age of menopause, and they took a hormone mix that's rarely used today. In November 2025, the FDA said it would take off the warnings about heart disease, breast cancer and dementia. The first new labels came out in February 2026. One boxed warning stays on estrogen-only products. The bigger lesson goes past this one medicine. A label shows the best science of its time, and it can change when the science does. If a warning ever kept you from asking a question, you're still allowed to ask it.
THE BIGGER PICTURE This comeback is just getting started. π In 1999, about 1 in 4 women past menopause used hormone therapy. By 2020, it was fewer than 1 in 20. That's from a 2024 study in JAMA Health Forum. It found use dropped from 26.9% to 4.7%.
That means a whole generation of women went through menopause without the topic even coming up. Lots of doctors who trained in those years got very little practice with it.
Now the big warning is gone. A handful of states, including Illinois, Louisiana and New Jersey, now require insurance to cover menopause treatment, and more states are looking at it.
That's why the doctor's message to drug makers was simple: plan for more. This wave has plenty of room to grow.
For the rest of us, the takeaway is even simpler. Hormone therapy isn't right for everyone. But if you're in your 40s or 50s and something feels off, you're allowed to bring it up.
Got a friend who's been quietly sweating through it? Send this to her. π